Current Appointments & Affiliations
Biostatistician, Principal
Duke Clinical Research Institute,
Institutes and Centers
Recent Publications
Major Bleeding With Apixaban vs Aspirin: A Subanalysis of the ARTESiA Randomized Clinical Trial.
Journal Article JAMA Cardiol · December 1, 2025 IMPORTANCE: The Apixaban for the Reduction of Thromboembolism in Patients With Device-Detected Subclinical Atrial Fibrillation (ARTESiA) randomized clinical trial showed that in patients with subclinical atrial fibrillation (SCAF) apixaban, compared with a ... Full text Link to item CiteBlood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trial.
Journal Article Eur J Heart Fail · September 29, 2025 AIMS: The efficacy and safety of vericiguat in patients with chronic heart failure with reduced ejection fraction (HFrEF) on contemporary heart failure (HF) therapies and without recent worsening was investigated in the VICTOR trial, yet some subgroups may ... Full text Link to item CiteAutomated Data Harmonization in Clinical Research: Natural Language Processing Approach.
Journal Article JMIR Form Res · August 27, 2025 BACKGROUND: Integrating data is essential for advancing clinical and epidemiological research. However, because datasets often describe variables (eg, demographic and health conditions) in diverse ways, the process of integrating and harmonizing variables ... Full text Link to item CiteRecent Grants
Improving Quality of Life in SLE by Stratified Personalized Health Planning
ResearchBiostatistician · Awarded by Department of Defense · 2022 - 2026Secondary Analyses to Support the Rational Design of Clinical Trials in Chronic Lung Allograft Dysfunction
ResearchBiostatistician · Awarded by National Institutes of Health · 2023 - 2025Debiasing Clinical Care Algorithms
ResearchStatistical Programmer · Awarded by American Heart Association · 2024 - 2025View All Grants